Moreover, RM was 10-fold more sensitive in p53 mutant MDA-MB-435 melanoma than in p53 wild type HCT116 colon carcinoma [2], supporting the hypothesis that p53 may not be required in the cytotoxicity of RM. The gene discussed is TP53; the disease is colon carcinoma.